A Study to Evaluate the Safety and Tolerability of Venetoclax Tablets in Combination With Capecitabine Tablets in Adult Participants With Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer Who Had Disease Progression During or After CDK4/6 Inhibitor Therapy
Clinical trial NCT04274933 · TERMINATED
Trial details
- NCT number
- NCT04274933
- Sponsor
- AbbVie
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-21
- Primary completion
- 2020-10-08
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.